INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Cutting Corners In RTSM Software Increases Speed...And RISK!

  Discover why true RTSM efficiency requires rigor, not shortcuts — highlighting how thoughtful processes and clear communication deliver speed without compromising quality or introducing avoidable risk.

• Streamlining Translations For Global Studies

  Ensure seamless, accurate global study translations and efficient localization with IQVIA eCOA, leveraging our proven vendor relationships and streamlined process to keep your study on track.

• How Emerging Technologies Are Challenging Traditional IRB Oversight

  Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.

• The Role And Importance Of Enterprise Data Archiving In Life Sciences

  Ensure long-term GxP compliance and audit readiness by centralizing fragmented records. Learn to preserve data integrity and reduce IT overhead while keeping vital information accessible.

• AI in Pharma: Benefits, Risks, And The Road Ahead

  10/23/2024

  How could leveraging AI technologies, including machine learning (ML) and generative AI (GenAI), enable your company to streamline processes from drug discovery to post-launch?

• The Fastest Route To Compliant Medical Device Trials

  7/24/2026

  Watch a live build of compliant eCRFs and ePROs and see how lean teams can go from protocol to first patient faster without sacrificing regulatory readiness.

• Navigating eCOA Licensing And Localization In Clinical Trials

  7/31/2025

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• Building A Clinical Research AI Governance Framework

  6/15/2026

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models

  7/6/2026

  Human challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.